Clinical Trial Update: Anxiety, Inflammation, Stress, and Cannabinoids

View source ↗

Summary

A completed clinical trial from University of Colorado Boulder assessed cannabinoids for anxiety and inflammation; results were posted in December 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Generalized Anxiety Disorder
• Inflammation

Drugs mentioned

• Cannabinoids (unspecified) (cannabinoids)

Snippet

Sponsor: University of Colorado, Boulder | Conditions: Anxiety, Anxiety Disorders | Status: COMPLETED | Results posted: 2024-12-09